Please assess the completion status of the following clinical trial:

Trial Title: PICC Asymptomatic Thrombosis Study: A Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient is indicated for a medically necessary PICC for therapeutic delivery medication~2. Patient is eligible to receive a single lumen PICC~3. Patient is an adult who is prescribed a PICC line~4. Patient's expected duration of treatment requiring a PICC for a minimum of 16 days post device implantation~5. Patient understands and is willing to comply with all study requirements and has voluntarily signed the Informed Consent Form (ICF).~Exclusion Criteria:~1. Is pregnant, lactating, or is planning to become pregnant during the time of the study~2. Has been previously enrolled in this post market clinical evaluation, or is participating in another clinical study that is contraindicative to the treatment or outcomes of this investigation~3. Venous thrombosis in any portion of the vein to be catheterized~4. Conditions that impede venous return from the extremity such as paralysis or lymphedema after mastectomy~5. Orthopedic or neurological conditions affecting the extremity~6. Anticipation or presence of dialysis grafts or other intraluminal devices, including pacemakers, within a month of patient enrollment start~7. Patients who are on anticoagulation therapy prior to the study (10-14 days). Note: (If patients are placed on anticoagulation (low dose) therapy while hospitalized, these patients are allowed.)~8. Patient has relinquished control of care to a guardian and/or facility~9. Patient has any significant medical or physical condition that, in the opinion of the PI, would make the subject unsuitable for participation in the post market clinical evaluation~10. Inability to complete the protocol in the opinion of the clinical staff due to safety or other reasons

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hydrophilic BioMaterial (Type: ACTIVE_COMPARATOR): Hydrophilic BioMaterial- HydroPICC
- Thermoplastic Polyurethane (Type: ACTIVE_COMPARATOR): TPU- 4 French Single Lumen PowerPICC

Based on this trial design, predict the completion outcome and termination type (if applicable).